Articles

Dive into our comprehensive collection of pharma and healthcare articles for expert analysis, strategic insights, and emerging trends across R&D, market access, digital health, and regulatory science — curated to inform, inspire, and empower your next move.

October 1, 2026

Beyond the Static Document: Why Evidence-Driven TPP Optimization Is Becoming a Strategic Imperative in Pharma

Every drug development program starts with a hypothesis about the…

September 24, 2026

Primary Market Research in Pharma: Turning Stakeholder Perspectives into Actionable Decisions

In pharma, more data doesn't always mean better answers.Secondary research…

September 15, 2026

The Evolution of HEOR in Rare Diseases: From Cost-Effectiveness to Strategic Market Access

There used to be a simple rule in pharma: scientists…

September 7, 2026

HER2-Positive Metastatic Breast Cancer: The Treatment Shift Reshaping the Market

A Decade of Reinvention There was a time when a…